PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 74 filers reported holding PMV PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,655,326 | +1.8% | 269,597 | +3.8% | 0.00% | – |
| Q2 2023 | $1,626,611 | +34.5% | 259,842 | +2.5% | 0.00% | – |
| Q1 2023 | $1,209,071 | -44.8% | 253,474 | +0.6% | 0.00% | -100.0% |
| Q4 2022 | $2,192,043 | -25.9% | 251,959 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $2,957,000 | -2.5% | 248,476 | +16.7% | 0.00% | 0.0% |
| Q2 2022 | $3,034,000 | -25.2% | 212,897 | +9.2% | 0.00% | 0.0% |
| Q1 2022 | $4,058,000 | -7.4% | 194,876 | +2.7% | 0.00% | 0.0% |
| Q4 2021 | $4,384,000 | -21.4% | 189,779 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $5,578,000 | +42.8% | 187,163 | +63.8% | 0.00% | +100.0% |
| Q2 2021 | $3,905,000 | +39.5% | 114,288 | +34.3% | 0.00% | 0.0% |
| Q1 2021 | $2,799,000 | -45.3% | 85,085 | +2.3% | 0.00% | -50.0% |
| Q4 2020 | $5,116,000 | – | 83,164 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |